Sempulse — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Sempulse is a private medical device and digital health company founded in 2018, focused on transforming remote patient monitoring through its integrated hardware and software platform. Its core product, the Halo sensor, is a miniature, rugged, FDA-cleared device worn behind the ear that continuously tracks blood pressure, pulse oximetry, heart rate, respiratory rate, and body temperature. The platform leverages AI and machine learning to automate data analysis, triage prioritization, and alerts, aiming to improve clinical decision-making and resource allocation across diverse environments from hospitals to battlefield triage.

Drug DeliveryMedical DevicesRespiratory

Technology Platform

Integrated hardware/software platform featuring the Halo wearable sensor (monitors NIBP, SpO2, heart rate, respiratory rate, temperature, activity), the LiveCharts mobile app for real-time multi-patient viewing, the Command Cloud secure database, and Life Analytics AI/ML for automated prognoses and alerts.

Opportunities

Sempulse has a significant opportunity to capitalize on the massive growth in remote patient monitoring and telehealth, driven by an aging population and cost pressures in healthcare.

Its unique ability to serve high-value niche markets like military/defense and industrial safety provides diversified revenue streams and potential for non-dilutive government funding.

The platform's multi-parameter, clinical-grade data also positions it as a potential foundational tool for AI-driven predictive analytics in hospital-at-home and decentralized clinical trials.

Risk Factors

Key risks include intense competition in the crowded remote monitoring space from both large medtech firms and agile startups, which could challenge market penetration and pricing.

The company also faces the dual challenge of complex sales cycles in healthcare and government procurement, requiring significant capital and a strong commercial team to drive adoption.

Ongoing regulatory compliance for its software and the need for continuous clinical validation to prove cost-effectiveness and outcome improvements present additional operational and financial burdens.

Competitive Landscape

Sempulse competes in the broader remote patient monitoring market against large, established players like Medtronic, Philips, and GE Healthcare, which offer comprehensive hospital monitoring systems, and against a plethora of startups focused on specific vital signs or conditions (e.g., BioIntelliSense, Current Health, VitalConnect). Its key differentiation is the combination of a truly wearable, multi-parameter (especially cuffless blood pressure), clinical-grade sensor with a scalable software platform designed for mass monitoring scenarios, setting it apart from both single-parameter wearables and bulky hospital monitors.

More companies in Digital Health & Biotech SaaS →More companies in United States →